Model
Edge
Alnylam Pharmaceuticals, Inc.
0001219016
Filing type
4
Filing date
May 18, 2025
Updated
May 19, 2025 ยท 2:17 PM
Copy reference
Filing
4
Statement of Changes in Beneficial Ownership